EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Prevention of gram positive g positive bacteremia ba with low dose vancomycin va infusion



Prevention of gram positive g positive bacteremia ba with low dose vancomycin va infusion



Pediatric Research 31(4 PART 2): 278A




(PDF 0-2 workdays service: $29.90)

Accession: 032944115

Download citation: RISBibTeXText



Related references

Protocol for continuous low-dose Vancomycin infusion for prevention of gram-positive sepsis in neonates weighing less than 1500 grams. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 36(0): 237, 1996

Treating Gram-positive infections: vancomycin update and the whys, wherefores and evidence base for continuous infusion of anti-Gram-positive antibiotics. Current Opinion in Infectious Diseases 22(6): 525-534, 2010

Continuous infusions of low dose vancomycin va in neonates prevents gram positive bacteremia g plus ba without altering va susceptibilities. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 32: 154, 1992

Linezolid vs vancomycin in children with resistant gram-positive bacteremia. Pediatric Research 53(4 Part 2): 322A, April, 2003

The clinical impact of early gram-positive bacteremia and the use of vancomycin after allo-BMT. Blood 94(10 SUPPL 1 PART 2): 372b, Nov 15, 1999

Prevention of gram-positive infections in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomized controlled trial of vancomycin. Pediatric Hematology and Oncology 12(1): 73-77, 1995

Leuconostoc bacteremia after liver transplantation: another cause of vancomycin resistant gram-positive infection. Clinical Transplantation 11(4): 322-324, 1997

Association of vancomycin serum concentrations with outcomes in patients with gram-positive bacteremia. PharmacoTherapy 15(1): 85-91, 1995

Vancomycin versus teicoplanin for the treatment of gram-positive bacteremia in patients with cancer. Journal of Infectious Diseases 170(5): 1344-1345, 1994

Use of vancomycin for the prevention of gram positive sepsis in very low birth weight premature infants Update on development of vancomycin resistance. Pediatric Research 51(4 Part 2): 306A, April, 2002

Gram positive infection in trauma patients: new strategies to decrease emerging Gram-positive resistance and vancomycin toxicity. International Journal of Antimicrobial Agents 16 Suppl 1: S39-S42, 2001

Gram positive infection in trauma patients: New strategies to decrease emerging Gram-positive resistance and vancomycin toxicity. International Journal of Antimicrobial Agents 16(Supplement 1): S39-S42, November, 2000

Pharmacodynamic evaluation of teicoplanin versus vancomycin in the treatment of Gram-positive bacteremia and endocarditis. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 36(0): 7, 1996

Randomized double blind study of teicoplanin t and vancomycin v in gram positive bacteremia gpb and endocarditis gpe. Clinical Research 39(4): 809A, 1991

Weissella confusa: an unexpected cause of vancomycin-resistant gram-positive bacteremia in immunocompromised hosts. Transplant Infectious Disease 13(3): 294-298, 2011